发明名称 |
SPIRO COMPOUNDS, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THE COMPOUNDS |
摘要 |
<p>Spiro compounds represented by the following general formula (I) or pharmaceutically acceptable acid-addition salts thereof: (I) wherein R<1> and R<2> are the same or different and each represents hydrogen, chlorine, etc.; n is 1, 2 or 3; a bond having a broken line represents a single or double bond; and A represents -X-(CH2)q-N(R<3>)(R<4>), a group represented by the following general formula (a), etc. (a) (wherein X represents oxygen or sulfur; q is 2 or 3; R<3> and R<4> are the same or different and each represents C1-6 alkyl, etc., or R<3> and R<4 >may form together with the adjacent nitrogen atom a piperidine ring, etc. optionally having one or two C1-6 alkyl substituents, etc.; R<5> represents C1-6 alkyl, etc.; R<6> represents hydrogen, etc.; and r and t independently represent each 1 or 2. These compounds are useful as selective estrogen receptor modulators having an effect of ameliorating symptoms of menopause. They are also expected as being usable as preventives and/or remedies for osteoporosis, symptoms of menopause and breast cancer.</p> |
申请公布号 |
WO2004031125(A1) |
申请公布日期 |
2004.04.15 |
申请号 |
WO2003JP04889 |
申请日期 |
2003.04.17 |
申请人 |
DAINIPPON PHARMACEUTICAL CO., LTD.;WATANABE, NOBUHIDE;NAKAGAWA, HIROSHI;TSUJI, JUN-ICHI;MINATO, HISAO;IKENO, AKIHISA;KOHAYAKAWA, CHIE |
发明人 |
WATANABE, NOBUHIDE;NAKAGAWA, HIROSHI;TSUJI, JUN-ICHI;MINATO, HISAO;IKENO, AKIHISA;KOHAYAKAWA, CHIE |
分类号 |
A61K31/451;A61K31/40;A61K31/445;A61K31/4453;A61K31/495;A61K31/55;A61P15/12;A61P19/10;A61P35/00;A61P43/00;C07C217/20;C07C217/24;C07D211/14;C07D295/092;(IPC1-7):C07C217/18;C07D295/096;A61K31/138;C07D295/088;C07D211/22 |
主分类号 |
A61K31/451 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|